Perth-based telco Vonex lists on the ASX

|

Published 14-JUN-2018 14:44 P.M.

|

3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Perth-based telecommunications provider Vonex Limited (ASX:VN8) commenced trading on the ASX yesterday, under the code VN8 and option ticker code VN8O.

As stated in the announcement, VN8’s listing “represents the culmination of hard work and support from various stakeholders” with management seeing it as a transformational step forward for the telco provider and industry innovator.

VN8 is now well funded following the A$6 million IPO, providing the opportunity for it to turn its focus towards expanding its business units, as well as the development of new cutting-edge products.

“I would like to take this opportunity to thank everyone for their support over the last couple of years and extend special thank you to Alan Hill and State One Equities for their efforts in supporting the IPO. Today is a truly momentous day for Vonex and we look forward to providing further updates in due course,” Managing Director, Matthew Fahey said.

It should be noted that Vonex remains a speculative stock and investors should seek professional financial advice if considering this stock for their portfolio.

Now that it’s landed successfully on the ASX, the company will be concentrating on three main areas as detailed below.

Vonex Telecom – Retail

The company intends to kick-start its expansion plans through its retail business Vonex Telecom. Accelerated efforts towards its marketing and channel partners will be designed to maximise the opportunities inherent within the rollout of the NBN over the next three years.

The NBN is currently being rolled out in high-density city areas, which will cause a ‘churn event’ (compulsory change in internet connections and therefore the opportunity to change providers) impacting a large number of small to medium enterprises, which is VN8’s target market.

As all Australians will be required to change from the old copper network to the NBN, there will be an unprecedented opportunity for smaller, newer providers like VN8 to get noticed by customers seeking the best internet package available.

The small-cap has an existing channel partner program through which its products are promoted to customers, however the company will be further expanding the program to drive additional sales, while also kicking off its own aggressive marketing campaign in parallel.

Oper8tor App to enter Beta stage

VN8 has been hard at work developing a social media app called Oper8tor, which is currently in the Alpha stage with plans to enter the Beta trial stage in the near-term.

The small cap sees significant potential for the proprietary App, as the only one of its kind in the world which allows multiple social media voice apps to operate seamlessly together.

Watch this video to see what the Oper8tor App is and how it works:

Evaluation of Vonex’s Wholesale division

The third area of focus for VN8 now that it’s gone public will be its wholesale business. The company plans to conduct a thorough evaluation of this division as a first step towards expanding the products and services it offers.

It is this division where VN8 sells its proprietary voice, VoIP, PBX and advanced features tech on a white label basis to clients (other telcos in particular), which can be subsequently on-sold under their own brand.

The plan for its wholesale vision will be to attract new white‐label carrier businesses to the group, both in Australia and overseas.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X